Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability

Figure 4

Evaluation of the GIRlncPSig in the testing and TCGA sets. (a) K-M curves indicating OS in high- and low-risk group patients as classified using the GIRlncPSig in the testing and (e) TCGA sets. (b) Time-dependent ROC curves analysis of the GIRlncPSig at three years in the testing and (f) TCGA sets. (c) The distribution of somatic mutation, MLH1 expression, and lncRNA expression with increasing risk scores in the testing and (g) TCGA sets. (d) Total somatic mutation and MLH1 expression levels in the high- and low-risk groups in the testing and (h) TCGA sets.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)